Oramed Pharmaceuticals, Inc. (ORMP)
4.13
+0.01
(+0.24%)
USD |
NASDAQ |
Oct 23, 16:00
4.14
+0.01
(+0.24%)
After-Hours: 20:00
Oramed Pharmaceuticals Market Cap : 170.63M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 170.63M |
| October 22, 2026 | 170.21M |
| October 21, 2026 | 171.04M |
| October 20, 2026 | 171.45M |
| October 19, 2026 | 167.74M |
| October 16, 2026 | 168.15M |
| October 15, 2026 | 172.69M |
| October 14, 2026 | 171.04M |
| October 13, 2026 | 172.28M |
| October 12, 2026 | 176.41M |
| October 09, 2026 | 178.89M |
| October 08, 2026 | 173.52M |
| October 07, 2026 | 180.54M |
| October 06, 2026 | 180.96M |
| October 05, 2026 | 187.98M |
| October 02, 2026 | 185.50M |
| October 01, 2026 | 185.09M |
| September 30, 2026 | 192.94M |
| September 29, 2026 | 193.76M |
| September 28, 2026 | 196.24M |
| September 25, 2026 | 195.42M |
| September 24, 2026 | 197.90M |
| September 23, 2026 | 195.00M |
| September 22, 2026 | 196.24M |
| September 21, 2026 | 194.18M |
| Date | Value |
|---|---|
| September 18, 2026 | 195.83M |
| September 17, 2026 | 192.94M |
| September 16, 2026 | 190.87M |
| September 15, 2026 | 190.87M |
| September 14, 2026 | 192.94M |
| September 11, 2026 | 192.52M |
| September 10, 2026 | 196.66M |
| September 09, 2026 | 197.48M |
| September 08, 2026 | 205.74M |
| September 04, 2026 | 206.98M |
| September 03, 2026 | 203.68M |
| September 02, 2026 | 209.46M |
| September 01, 2026 | 200.37M |
| August 31, 2026 | 207.40M |
| August 28, 2026 | 207.81M |
| August 27, 2026 | 210.70M |
| August 26, 2026 | 220.62M |
| August 25, 2026 | 215.25M |
| August 24, 2026 | 199.13M |
| August 21, 2026 | 198.72M |
| August 20, 2026 | 197.90M |
| August 19, 2026 | 197.90M |
| August 18, 2026 | 197.48M |
| August 17, 2026 | 188.81M |
| August 14, 2026 | 185.09M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ANI Pharmaceuticals, Inc. | 1.668B |
| Corcept Therapeutics, Inc. | 9.266B |
| Veru, Inc. | 38.19M |
| Johnson & Johnson | 635.02B |
| Eli Lilly & Co. | 1.199T |
Market Cap Related Metrics
| PE Ratio | 1.005 |
| Price to Book Value | 0.5375 |
| Price | 4.13 |
| Earnings Yield | 99.53% |
| Normalized PE Ratio | 3.940 |